Art

J-GLOBAL ID：201102230747107098   Reference number：11A0966794

Clinically isolated syndrome: prognostic markers for conversion to multiple sclerosis and initiation of disease-modifying therapy

Clinically isolated syndrome-多発性硬化症への進展予測と病態修飾療法の開始-

Author (1)： KOORIYAMA TATSUO (広島市立広島市民病院神経内科)
Material： 臨床神経学  (Clinical Neurology)
Volume： 51  Issue： 3  Page： 179-187 (J-STAGE)  Publication year： 2011 
JST Material Number： Z0689A  ISSN： 0009-918X  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *multiple sclerosis ,...
Semi thesaurus term： 進展予測 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A0966794&from=J-GLOBAL&jstjournalNo=Z0689A") }}

JST classification (2)： Clinical neurology in general  (GN01030H) ,  Immunologic diseases,allergic diseases in general.  (GD04010C)

Reference (58)：

• The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology. 1993, 43, 655-661
• The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis : final outcome of the randomized controlled trial. Neurology. 1995, 45, 1277-1285
• JACOBS, LD. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol. 1996, 39, 285-294
• PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet. 1998, 352, 1498-1504
• MILLER, D. Clinically isolated syndromes suggestive of multiple sclerosis. part I : natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol. 2005, 4, 281-288

Terms in the title (6)： 多発性硬化症 ,  進展 ,  予測 ,  病態 ,  修飾 ,  療法